Not applicableStudy completedNCT02389387What this trial is testingReducing Disparities in Access to Kidney Transplantation (RaDIANT) Regional StudyWho this might be right forEnd-stage Renal Disease Emory University 440
Not applicableActive Not RecruitingNCT05729620What this trial is testingEvaluation of STARgraft-3 for HemodialysisWho this might be right forEnd Stage Renal Disease Healionics Corporation 21
Not applicableEnded earlyNCT01601873What this trial is testingPropaten Randomized Investigation on Cost-benefit and EfficacyWho this might be right forEnd-stage Renal Disease The University of Texas Health Science Center, Houston 103
Not applicableStudy completedNCT00565994What this trial is testingCytokine and Inflammatory Markers in Patients With Chronic Renal FailureWho this might be right forChronic Renal Failure University of Oklahoma 60
Not applicableUnknownNCT04285073What this trial is testingProspective, Multicenter, Non-randomized, Single Arm Clinical Trial to Evaluate the Safety and Efficacy of e-PTFE Grafts Inner Surface-treated With Paclitaxel as an Access for Hemodialysis in Patients With End-stage Renal Disease.Who this might be right forHemodialysis Access Failure Samsung Medical Center 20
Not applicableApproved For MarketingNCT02411604What this trial is testingExpanded Access Study for Renal Transplant Patients With Envarsus XR ™Who this might be right forRenal Failure Veloxis Pharmaceuticals
Not applicableActive Not RecruitingNCT05473299What this trial is testingXeltis Hemodialysis Access Graft: aXess Pivotal StudyWho this might be right forEnd-stage Renal Disease Xeltis 120
Not applicableUnknownNCT03234075What this trial is testingEvaluation of a New Regional Organization to Promote Access to Renal TransplantationWho this might be right forRenal Failure Hospices Civils de Lyon 4,000
Not applicableNo Longer AvailableNCT00149981What this trial is testingA Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ TransplantationWho this might be right forOrgan Transplantation Novartis Pharmaceuticals
Post-approval studies (Phase 4)Ended earlyNCT02099344What this trial is testingArtegraft Versus Propaten Dialysis GraftsWho this might be right forESRDRenal Failure Kaiser Permanente 1
Not applicableLooking for participantsNCT06809075What this trial is testingImmunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant Candidates Through Non-myeloablative Autologous Stemm Cell TransplantationWho this might be right forKidney DiseaseKidney TransplantKidney Transplant Candidates Hospital Universitari Vall d'Hebron Research Institute 10
Not applicableLooking for participantsNCT07555717What this trial is testingSTARgraft (10401) PilotWho this might be right forEnd Stage Kidney Disease (ESRD) Healionics Corporation 20
Not applicableWithdrawnNCT06707038What this trial is testingImproving Access to Renal Transplantation for Underserved Black CommunitiesWho this might be right forKidney TransplantESRD (End Stage Renal Disease) Northwestern University
Very early researchWithdrawnNCT02695641What this trial is testingReduction of Plasma Free VEGF-A Using Low-dose Bevacizumab in Hemodialysis PatientsWho this might be right forEnd Stage Renal DiseaseHemodialysis Vascular Access Failure Mayo Clinic
Not applicableLooking for participantsNCT04671771What this trial is testingEvaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal DiseaseWho this might be right forEnd Stage Renal Disease (ESRD)Kidney FailureChronic Renal Disease+1 more W.L.Gore & Associates 133
Not applicableStudy completedNCT02649946What this trial is testingClinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent GraftWho this might be right forStenosisRestenosis C. R. Bard 280
Post-approval studies (Phase 4)WithdrawnNCT04614142What this trial is testingSingle Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis AccessWho this might be right forEnd Stage Renal DiseaseChronic Hepatitis c Massachusetts General Hospital
Post-approval studies (Phase 4)Ended earlyNCT01623583What this trial is testingEffect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle PhobiasWho this might be right forNeedle PhobiaPhobic Disorders Davita Clinical Research 10
Not applicableLooking for participantsNCT05612022What this trial is testingAcoustic Analysis of VA SoundsWho this might be right forEnd Stage Renal DiseaseHemodialysis Access Failure Mario Negri Institute for Pharmacological Research 44
Not applicableEnded earlyNCT03300024What this trial is testingBovine Carotid Artery Biologic Graft and Expanded Polytetrafluoroethylene for Permanent Hemodialysis AccessWho this might be right forEnd Stage Renal DiseaseHemolysisArteriovenous Graft Johns Hopkins University 10